Multistage Vectored siRNA Targeting Ataxia-Telangiectasia Mutated for Breast Cancer Therapy-Reference-Cited by-同舟云学术

Multistage Vectored siRNA Targeting Ataxia-Telangiectasia Mutated for Breast Cancer Therapy

Published:2013-01-06 Issue:9-10 Volume:9 Page:1799-1808
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Xu Rong,Huang Yi,Mai Junhua,Zhang Guodong,Guo Xiaojing,Xia Xiaojun,Koay Eugene J.,Qin Guoting,Erm Donald R.,Li Qingpo,Liu Xuewu,Ferrari Mauro,Shen Haifa

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/smll.201201510/fullpdf

Reference49 articles.

1. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

2. Effects of Estrogen Receptor Expression and Histopathology on Annual Hazard Rates of Death from Breast Cancer

3. HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

4. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer

5. PARP inhibitors – current status and the walk towards early breast cancer

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy;Bioengineering;2024-08-14

2. Exploring wetting & scaling behavior of rough silicon surfaces;Radiation Effects and Defects in Solids;2024-01-02

3. Silicon-containing nanomedicine and biomaterials: materials chemistry, multi-dimensional design, and biomedical application;Chemical Society Reviews;2024

4. Liposomal ATM siRNA delivery for enhancing triple-negaitive breast cancer immune checkpoint blockade therapy;Journal of Biomaterials Applications;2023-04-04

5. Triple-Negative Breast Cancer Therapy: Recent Advances, Challenges, and Future Perspective;Interdisciplinary Cancer Research;2023